Olympus (OTCMKTS:OCPNY) Stock Passes Below 200 Day Moving Average – Here’s What Happened

Shares of Olympus Co. (OTCMKTS:OCPNY) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares traded.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised Olympus to a “buy” rating in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy”.

Olympus Stock Down 1.4%

The stock has a market capitalization of $23.15 billion, a PE ratio of 21.95, a P/E/G ratio of 1.07 and a beta of 0.70. The firm has a 50 day moving average of $18.00 and a two-hundred day moving average of $18.00. The company has a current ratio of 1.99, a quick ratio of 1.48 and a debt-to-equity ratio of 0.59.

About Olympus

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.